China ophthalmic surgical instruments market is expected to reach at a healthy CAGR of 13.5% in the forecast period of 2019 to 2026.
Segmentation: China Ophthalmic Surgical Instruments Market
China ophthalmic surgical instruments market is segmented based on products, application and end user.
- On the basis of products, the market is segmented into cataract surgery devices, glaucoma surgery devices, refractive surgery devices, vitreoretinal surgery devices, ophthalmic microscopes and ophthalmic surgical accessories.
- In December 2018, Alcon the division of the Novartis AG announced the launch of iLux Device which is used in the customizable treatment for the dysfunction of meibomian gland. The expanding of the portfolio helps in the technology development and their availability.
- On the basis of application, the market is segmented into cataract, glaucoma, refractive, vitreoretinal, diabetic retinopathy and others.
- In October 2018, Bausch + Lomb a division of the Bausch Health Companies Inc announced the introduction of eyeTELLIGENCE applications which can be opted on IBM Cloud to help in the surgical facility and eye surgeons.
- On the basis of end user, the market is segmented into hospitals, specialty clinics and ambulatory centers.
- In February 2019, Ziemer Ophthalmic Systems AG announced the production of the 1000th laser FEMTO LDV. This has helped in the expansion of product portfolio.
Competitive Analysis: China Ophthalmic Surgical Instruments Market
Some of the major players operating in this market are Novatis AG, Johnson & Johnson Services, Inc., ZEISS International, BAUSCH HEALTH, HOYA Corporation, Ellex Medical Lasers Ltd., IRIDEX Corporation, Leica Microsystems, Lumenis, NIDEK CO., LTD., Quantel Medical, STAAR SURGICAL, TOPCON CORPORATION and Ziemer Ophthalmic Systems.
- In October 2018, Quantel Medical announced the launch of VITRA 810 laser and SubCyclo probe. The VITRA 810 laser and SubCyclo probe is used for the treatment of ocular diseases and offers clinical applications. The introduction of the device will sustain the position of the company in glaucoma treatment.
- In September 2018, Quantel Medical announced launch of the ABSoluultrasound platform. The product is designed with the advanced technology and provides unparalleled image quality at unexceptional level. The company has set a new position with launch of the product for ophthalmologist.
- In June 2018, Quantel Medical announced the launch of LacryDiag which is a solution for the dry eyes. The device is CE marked and approved by the U.S. Food and Drug Administration (FDA).
Research Methodology: China Ophthalmic Surgical Instruments Market
Primary Respondents: Key Opinion Leaders (KOL’s): Doctors, Surgeons, Nurses, Researchers, Medical and Industrial Professionals, CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.